Cargando…
Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma
BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is an aggressive and complex disease characterized by wide clinical, phenotypic and molecular heterogeneities. The expression pattern and clinical implication of long non-coding RNAs (lncRNAs) between germinal center B-cell-like (GCB) and activated B...
Autores principales: | Zhou, Meng, Zhao, Hengqiang, Xu, Wanying, Bao, Siqi, Cheng, Liang, Sun, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248456/ https://www.ncbi.nlm.nih.gov/pubmed/28103885 http://dx.doi.org/10.1186/s12943-017-0580-4 |
Ejemplares similares
-
Discovery of potential prognostic long non-coding RNA biomarkers for predicting the risk of tumor recurrence of breast cancer patients
por: Zhou, Meng, et al.
Publicado: (2016) -
Identification and validation of a two-gene expression index for subtype classification and prognosis in Diffuse Large B-Cell Lymphoma
por: Xu, Qinghua, et al.
Publicado: (2015) -
A potential panel of six-long non-coding RNA signature to improve survival prediction of diffuse large-B-cell lymphoma
por: Sun, Jie, et al.
Publicado: (2016) -
Identification of microtubule-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023) -
Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023)